Key facts
- Notable investors include Yunqi Partners, Dalton Venture.
- Status: Privately Held (backing).
Investors
2- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for Kongshanci
- ·The full record, as it builds
Funding rounds
No funding rounds for Kongshanci are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Kongshanci
Developer of high-performance neuromodulation systems intended for treating mental and cognitive disorders. The company provides R&D and clinical translation, enabling industry users to access evidence-based therapy solutions.
- Sector
- Healthcare
- HQ
- Shanghai, China
- Founded
- 2024
- Website
- kongshanci.com/
- Ownership
- Privately Held (backing)
Kongshanci doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Kongshanci shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Kongshanci in its N-PORT filings yet. We sweep new filings monthly.